bioRxiv / medRxiv
open access
COVID-19 mRNA Vaccination Reduces Guillain-Barre Syndrome Risk: Evidence from a Large Longitudinal Cohort Study
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- mRNA COVID-19 vaccines: science versus misinformation.#247471
- The COVID-19 VaccinE Response and Co-Administration in Rheumatology Patients (COVER-CoAd)#913664
- Guillain–Barré syndrome associated with immune checkpoint inhibitors exposure: a pharmacovigilance study#676798
- Longitudinal proteomics defines stage-specific molecular signatures in Guillain-Barre syndrome#303457
- Immune Priming and the Risk of COVID-19, Influenza, and Other Acute Respiratory Infections: Insights From an N3C Cohort.#123163
Record · ID 424117
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive